American Heart Journal
Volume 150, Issue 2 , Pages 251-256, August 2005

Reproducibility of nitrate-stimulated tilt testing in patients with suspected vasovagal syncope and a healthy control group

  • Arnaud J.J. Aerts, MD

      Affiliations

    • Department of Cardiology, Atrium Medisch Centrum, Heerlen, The Netherlands
    • Corresponding Author InformationReprint requests: Arnaud J.J. Aerts, MD, Department of Cardiology, Atrium Medisch Centrum, Henri Dunantstraat 5, 6401 CX, Heerlen, The Netherlands.
  • ,
  • Paul Dendale, PhD

      Affiliations

    • Department of Cardiology, Virga Jesse Hospital Hasselt, Belgium
  • ,
  • Pierre Block, PhD

      Affiliations

    • Department of Cardiology, University Hospital, Vrije Universiteit Brussel, Brussels, Belgium
  • ,
  • Willem R.M. Dassen, PhD

      Affiliations

    • Department of Cardiology, University Hospital Maastricht, Maastricht, The Netherlands

Received 11 May 2004; accepted 1 August 2004.

Objective

Nitrate-stimulated tilt testing may be used to diagnose vasovagal syncope or to guide therapy. To date, the reproducibility of the test in patients with clinically suspected vasovagal syncope and healthy controls is undetermined. A high reproducibility is a prerequisite for correct interpretation of the test result. This study investigates the reproducibility of a nitrate-stimulated tilt test in patients with clinically suspected vasovagal syncope and a healthy control group.

Methods and Results

We studied 43 patients (24 women, 19 men) with a typical history of vasovagal syncope and 18 healthy controls (3 women, 15 men). We used a combined tilt protocol with a 30-minute passive and 15-minute nitrate-stimulated phase. The second tilt test was performed 16 ± 12 days after the first. In both patients and controls, overall positive tilt responses were reproduced in the second test in 100%. In contrast to this, the reproducibility of an overall negative test was 50% in patients but 93% in controls. Overall hemodynamic responses to tilt were reproducible in 80%.

Conclusion

Nitrate-stimulated tilt testing in both patients with suspected vasovagal syncope and controls has an excellent reproducibility of positive results but a moderate reproducibility of negative results. Importantly, these results are still valid at a repeat interval of 2 weeks and longer. These data suggest that in patients with suspected vasovagal syncope, a nitrate-stimulated tilt test may provide a suitable tool to evaluate the efficacy of a therapeutic approach.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-8703(04)00492-2

doi:10.1016/j.ahj.2004.08.001

American Heart Journal
Volume 150, Issue 2 , Pages 251-256, August 2005